- Nuclear imaging devices are critical diagnostic tools used to visualize the structure and function of organs, tissues, and bones by detecting radiation from administered radiotracers. They play a vital role in improving disease detection, treatment planning, and monitoring across healthcare sectors
- The market is witnessing steady growth, fueled by the rising prevalence of chronic diseases, technological advancements in imaging modalities, growing demand for early diagnosis, and the expansion of healthcare infrastructure worldwide
- North America is expected to dominate the nuclear imaging devices market with a share of 43.32%, due to the presence of major market players, advanced healthcare infrastructure, and high healthcare spending
- Asia-Pacific is expected to be the fastest growing region in the nuclear imaging devices market during the forecast period due to rapid urbanization, increasing healthcare investments, and a growing aging population
- Single Photon-Emission Computed Tomography (SPECT) segment is expected to dominate the market with a market share of 58.38% due to its lower cost compared to PET (Positron Emission Tomography), broader availability, ability to perform a wide range of diagnostic applications (especially in cardiology and neurology), and continuous advancements in SPECT technology, such as hybrid SPECT/CT systems that improve image quality and diagnostic accuracy
